FTO and amyotrophic lateral sclerosis: Notably, the expression of multiple m6A-modified ALS risk genes was returned to control-like levels (vehicle-treated), suggesting that FTO inhibition may mitigate MN degeneration in ALS by modulating m6A-modified gene expression (Fig. 8e).